By: 4 January 2019
Zimmer Biomet and Apple collaborate to launch a major clinical study on the patient journey

Zimmer Biomet Holdings is working with Apple by using Apple Watch and iPhone to change the patient journey for two of the most common surgeries – knee and hip replacement.

This collaboration has yielded Zimmer Biomet mymobility™, an app that uses the Apple Watch to facilitate a new level of connection between patients and their surgical care teams, which can immediately impact the journey patients experience when they undergo these procedures.

In addition to the app, Zimmer Biomet is commencing the mymobility clinical study, designed to study the app’s impact on patient outcomes and overall costs for joint replacement patients. During this research study,patients will use Zimmer Biomet mymobility with Apple Watch as they progress through their hip or knee replacement journey. Researchers will combine patient-reported feedback with continuous health and activity data from an Apple Watch to provide new insights into the power of the Zimmer Biomet mymobility app to impact the standard of care for these common surgeries. The study was launched inOctober and has the possibility to enroll as many as 10,000 patient participants in the USA.

“We are incredibly excited to work with Apple to transform the knee and hip replacement experience for patients and surgeons,” said Bryan Hanson,president and CEO, Zimmer Biomet.

“At ZimmerBiomet, we are committed to improving care decisions through digital health and we are thrilled to launch one of the largest evidence-gathering clinical studies in orthopaedic history.”